Compound ID | 1309
Synonym(s): Tosatoxumab | AR-301
Class: Antibody (monoclonal antibody [mAb])
Spectrum of activity: | Gram-positive |
Details of activity: | Adjunctive therapy for VAP caused by S. aureus |
Institute where first reported: | Aridis |
Highest developmental phase: | Phase 3 |
Development status: | Active |
External links: | |
Guide to Pharmacology: | tosatoxumab |
Main Source: | https://aridispharma.com/ar-301/ |